Mar 24, 2025 8:30am EDT Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
Mar 13, 2025 7:30am EDT Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Mar 12, 2025 8:30am EDT Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
Dec 19, 2024 8:30am EST Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Dec 04, 2024 8:30am EST Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
Nov 13, 2024 8:30am EST Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
Oct 22, 2024 8:30am EDT Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
Sep 26, 2024 8:30am EDT Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Sep 23, 2024 8:57am EDT Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
Sep 04, 2024 8:00am EDT Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant